New York, United States, June 13, 2024 (GLOBE NEWSWIRE) — The global external stimulator market size will grow from $1.76 billion in 2023 to $2.46 billion by 2033, with a CAGR of of 3.41% during the forecast period.
Get a sample PDF brochure: https://www.sphericalinsights.com/request-sample/4495
An external pacemaker is a medical device used to control the rhythm and rhythm of the heart by stimulating it with electrical impulses. The heart can be electrically stimulated using these non-invasive devices as needed. Electrode adhesives are usually used to attach them to the surface of the skin. The rise of heart-related disorders as a global public health emergency can be attributed to multiple risk factors, including a sedentary lifestyle, high blood pressure, stress, and diabetes. The sharp increase in CVD-related mortality indicates an urgent need for effective preventive, diagnostic, and therapeutic techniques. There is a growing need for effective cardiac rhythm treatment methods due to the increase in individuals with heart blocks and arrhythmias. While waiting for more permanent treatment options, such as surgery or implanted devices, patients can receive non-invasive, temporary heart rate regulation through lifesaving external pacemakers. However, one of the main obstacles facing external pacemaker companies is the high cost of complex equipment. Potential problems that may arise after surgery to implant the devices can also cause challenges and increase medical costs. These factors may limit market growth and access for specific patient populations.
Browse key industry insights spread across 250 pages of 120 market data tables and figures and charts from the report on ” Global External Pacemaker Market Size, distribution and impact analysis of COVID-19, by product (single room and double room), by application (bradycardia and acute myocardial infarction), by end user (Hospitals, ambulatory surgical centers and others) and region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2023 – 2033.”
Buy Now Full Report: https://www.sphericalinsights.com/checkout/4495
The two-room segment accounts for the largest share of revenue in the market throughout the forecast period.
Based on product, the global external pacemaker market is segmented into single-chamber and dual-chamber. Among them, the two-room segment accounts for the largest revenue share in the market over the forecast period. There is hope that dual-chamber external pacemakers can significantly help the growing number of patients suffering from atrioventricular block. The right ventricle and right atrium store the two leads of these devices.
The bradycardia segment influences the global external cardiac pacemaker market during the forecast period.
On the basis of application, the global external cardiac pacemaker market is segmented into bradycardia and acute myocardial infarction. Among them, the bradycardia segment influences the global external cardiac pacemaker market during the forecast period. The main reason for this is the increasing frequency of recurrent arrhythmias, which can be attributed to various factors such as population aging, lifestyle-related risk factors and underlying heart disorders.
The hospital segment influences the global external pacemaker market during the forecast period.
Based on end-user, the global external pacemaker market is segmented into hospitals, ambulatory surgical centers, and others. Among them, the hospital segment influences the global external pacing stimulators market during the forecast period. The diagnosis, treatment and management of cardiovascular diseases requiring cardiac rhythm regulation are mainly handled in hospitals, which makes a significant contribution to the external pacemaker market.
Ask before you buy this research report: https://www.sphericalinsights.com/inquiry-before-buying/4495
North America dominates the market with the highest market share during the forecast period.
North America dominates the market with the highest market share during the forecast period. North America retained the largest market share due to a number of factors, including an aging population, an increasing rate of heart disease, the existence of significant industry players in the region, and a highly established healthcare system. . It improved the knowledge of healthcare stakeholders and the general public about the current state of technology. In addition, it is expected that some medical device manufacturers involved in the research and development of the adaptation of external stimulation stimulation stimulation of local market growth.
The Asia-Pacific region is expected to accelerate during the forecast period. The market is expected to grow due to a number of contributing reasons, such as sedentary lifestyles, poor eating habits and an aging population that increases the need for effective treatment alternatives such as external stimulants and increases the prevalence of CVD. The market in the area is also expanding as a result of better healthcare infrastructure, rising disposable income and easier access to medical services.
Competition analysis:
The report provides proper analysis of the key organizations/companies involved in the global market along with a comparative assessment mainly based on their product offering, business overviews, geographical presence, enterprise strategies, market segment share and SWOT analysis. The report also provides an elaborative analysis focusing on current company news and developments, which includes product development, innovations, joint ventures, partnerships, mergers and acquisitions, strategic alliances and others. This enables the assessment of overall competition within the market. Key vendors in the global external pacemaker market are Medtronic, OSYPKA MEDICAL, Fluke, Avery Biomedical Devices, Inc., Lepu Medical Technology (Beijing) Co., Ltd., Boston Scientific Corporation, Pacetronix.com, OSCOR Inc., Abbott , BIOTRONIK , Cook Medical, Reka Health Pte Ltd, ZOLL Medical Corporation, Spacelabs Healthcare and other key players.
Get discount @ https://www.sphericalinsights.com/request-discount/4495
Recent developments
- In July 2023, Abbott has approved the AVEIR dual-chamber (DR) pacemaker device with the US FDA. This system is the world’s first pacing system to treat people with moderate or abnormal heart rhythms. The newly approved device is a non-surgical approach to speeding up abnormal heartbeats.
Market segment
This study forecasts revenue at the global, regional and country levels from 2020 to 2033. Spherical Insights has segmented the global external cardiac pacemaker market based on the segments mentioned below:
Global External Pacemaker Market, by Product
- Single room
- Double room
Global External Pacemaker Market, by Application
- Bradycardia
- Acute myocardial infarction
Global External Pacemaker Market, by End User
- hospital
- Ambulatory Surgical Centers
- Others
Global External Pacemaker Market, Regional Analysis
- North America
- Europe
- Germany
- uk
- France
- Ital
- Spain
- Russia
- The rest of Europe
- Asia Pacific
- China
- Japan
- Indian
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentinian
- The rest of South America
- Middle East and Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- The rest of the Middle East and Africa
Browse similar reports
Global Life Science Reagents Market Size, Analysis of the impact of COVID-19, by product type (cell and tissue culture reagents, chromatographic reagents, clinical chemistry reagents, immunoassay reagents, molecular diagnostic reagents, microbiological reagents, and other product types), by end user ( Laboratories and Diagnosticators Hospitals, Academic and Research Institutes, and Other End Users), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030
Global Multiplex Assay Market Size, Analysis of the impact of COVID-19, by type (protein-based multiplex assays, nucleic acid-based multiplex assays, and other multiplex assays), by product (consumer and software), by technology (flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies), By Application (R&D and Clinical Diagnostics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2022 – 2032
Global Sterile Filtration Market Size, Breakdown and analysis of the impact of COVID-19, by product (cartridge filter, capsule filter, syringe filter and others) by end user (Pharmaceutical and biopharmaceutical companies, contract research organizations and research laboratories) and by region (Americas) North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) Analysis and Forecast 2022 – 2030
Global Viral Vector and Plasmid Testing Services Market Size, So and analysis of the impact of COVID-19, by testing services (safety, genetic characterization, purity, identity and potency), by end user (research organizations and pharmaceutical and biotech companies) and by region (North America, Europe, Asia – Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030
About Spherical Insights & Consulting
Spherical Views & Consulting is a market research and consulting firm that provides actionable market research studies, quantitative forecasting and trend analysis, provides forward-looking insight designed specifically for decision makers and helps ROI.
Which is catering to various industries such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For more information on your target market, please contact us below:
Phone: +1 303 800 4326 (US)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact us: https://www.sphericalinsights.com/contact-us
Follow us: LinkedIn | Facebook | I tweet
#Global #External #Pacemaker #Market #Size #Exceed #Billion #CAGR
Image Source : www.globenewswire.com